nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Central Nervous System Stimulation—Methamphetamine—obesity	0.331	1	CiPCiCtD
Methylphenidate—Hexylcaine—Diethylpropion—obesity	0.109	1	CrCrCtD
Methylphenidate—attention deficit hyperactivity disorder—Bupropion—obesity	0.0973	0.5	CpDpCtD
Methylphenidate—attention deficit hyperactivity disorder—Methamphetamine—obesity	0.0973	0.5	CpDpCtD
Methylphenidate—SLC6A4—obesity	0.0722	1	CbGaD
Methylphenidate—SLC6A3—Diethylpropion—obesity	0.0208	0.0916	CbGbCtD
Methylphenidate—SLC6A3—Sibutramine—obesity	0.0158	0.0694	CbGbCtD
Methylphenidate—SLC6A3—Phendimetrazine—obesity	0.0158	0.0694	CbGbCtD
Methylphenidate—SLC6A2—Diethylpropion—obesity	0.0152	0.067	CbGbCtD
Methylphenidate—SLC6A4—Sibutramine—obesity	0.0138	0.0607	CbGbCtD
Methylphenidate—SLC6A3—Phentermine—obesity	0.0119	0.0526	CbGbCtD
Methylphenidate—SLC6A3—Benzphetamine—obesity	0.0119	0.0526	CbGbCtD
Methylphenidate—SLC6A2—Phendimetrazine—obesity	0.0115	0.0508	CbGbCtD
Methylphenidate—SLC6A2—Sibutramine—obesity	0.0115	0.0508	CbGbCtD
Methylphenidate—SLC6A3—Phenylpropanolamine—obesity	0.0114	0.0502	CbGbCtD
Methylphenidate—SLC6A4—Phentermine—obesity	0.0104	0.046	CbGbCtD
Methylphenidate—SLC6A3—Bupropion—obesity	0.0102	0.0447	CbGbCtD
Methylphenidate—SLC6A3—Methamphetamine—obesity	0.00955	0.0421	CbGbCtD
Methylphenidate—SLC6A2—Benzphetamine—obesity	0.00874	0.0385	CbGbCtD
Methylphenidate—SLC6A2—Phentermine—obesity	0.00874	0.0385	CbGbCtD
Methylphenidate—SLC6A4—Methamphetamine—obesity	0.00835	0.0368	CbGbCtD
Methylphenidate—SLC6A2—Phenylpropanolamine—obesity	0.00834	0.0367	CbGbCtD
Methylphenidate—SLC6A2—Bupropion—obesity	0.00743	0.0327	CbGbCtD
Methylphenidate—SLC6A2—Methamphetamine—obesity	0.00699	0.0308	CbGbCtD
Methylphenidate—CYP2D6—Phentermine—obesity	0.00262	0.0115	CbGbCtD
Methylphenidate—CYP2D6—Bupropion—obesity	0.00223	0.00982	CbGbCtD
Methylphenidate—CYP2D6—Methamphetamine—obesity	0.00209	0.00923	CbGbCtD
Methylphenidate—CYP2D6—Cimetidine—obesity	0.00164	0.0072	CbGbCtD
Methylphenidate—SLC6A2—sympathetic nervous system—obesity	0.00114	0.273	CbGeAlD
Methylphenidate—SLC6A2—autonomic nervous system—obesity	0.000768	0.184	CbGeAlD
Methylphenidate—Cyclandelate—CES1—obesity	0.000555	0.715	CrCbGaD
Methylphenidate—SLC6A3—hindbrain—obesity	0.000401	0.0959	CbGeAlD
Methylphenidate—SLC6A4—hindbrain—obesity	0.000368	0.0878	CbGeAlD
Methylphenidate—SLC6A3—respiratory system—obesity	0.000245	0.0585	CbGeAlD
Methylphenidate—SLC6A4—respiratory system—obesity	0.000224	0.0536	CbGeAlD
Methylphenidate—SLC6A2—respiratory system—obesity	0.000198	0.0472	CbGeAlD
Methylphenidate—CYP2D6—hindbrain—obesity	0.000177	0.0423	CbGeAlD
Methylphenidate—SLC6A4—digestive system—obesity	0.000143	0.0341	CbGeAlD
Methylphenidate—SLC6A2—adrenal gland—obesity	0.00012	0.0286	CbGeAlD
Methylphenidate—Cyclopentolate—BCHE—obesity	0.00012	0.154	CrCbGaD
Methylphenidate—SLC6A4—endocrine gland—obesity	0.000118	0.0282	CbGeAlD
Methylphenidate—SLC6A2—endocrine gland—obesity	0.000104	0.0248	CbGeAlD
Methylphenidate—Dexmethylphenidate—SLC6A4—obesity	0.000101	0.13	CrCbGaD
Methylphenidate—CYP2D6—digestive system—obesity	6.88e-05	0.0164	CbGeAlD
Methylphenidate—CYP2D6—endocrine gland—obesity	5.68e-05	0.0136	CbGeAlD
Methylphenidate—CYP2D6—liver—obesity	5.12e-05	0.0122	CbGeAlD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	2.64e-05	0.000532	CcSEcCtD
Methylphenidate—Cough—Sibutramine—obesity	2.64e-05	0.000531	CcSEcCtD
Methylphenidate—Malnutrition—Bupropion—obesity	2.64e-05	0.000531	CcSEcCtD
Methylphenidate—Discomfort—Orlistat—obesity	2.63e-05	0.000529	CcSEcCtD
Methylphenidate—Convulsion—Sibutramine—obesity	2.62e-05	0.000527	CcSEcCtD
Methylphenidate—Hypertension—Sibutramine—obesity	2.61e-05	0.000525	CcSEcCtD
Methylphenidate—Dry mouth—Orlistat—obesity	2.6e-05	0.000524	CcSEcCtD
Methylphenidate—Dehydration—Topiramate—obesity	2.6e-05	0.000522	CcSEcCtD
Methylphenidate—Tension—Bupropion—obesity	2.59e-05	0.000521	CcSEcCtD
Methylphenidate—Liver function test abnormal—Topiramate—obesity	2.58e-05	0.000518	CcSEcCtD
Methylphenidate—Arthralgia—Sibutramine—obesity	2.58e-05	0.000518	CcSEcCtD
Methylphenidate—Myalgia—Sibutramine—obesity	2.58e-05	0.000518	CcSEcCtD
Methylphenidate—Chest pain—Sibutramine—obesity	2.58e-05	0.000518	CcSEcCtD
Methylphenidate—Anxiety—Sibutramine—obesity	2.57e-05	0.000516	CcSEcCtD
Methylphenidate—Nervousness—Bupropion—obesity	2.56e-05	0.000515	CcSEcCtD
Methylphenidate—Anaphylactic shock—Orlistat—obesity	2.55e-05	0.000513	CcSEcCtD
Methylphenidate—Oedema—Orlistat—obesity	2.55e-05	0.000513	CcSEcCtD
Methylphenidate—Back pain—Bupropion—obesity	2.55e-05	0.000513	CcSEcCtD
Methylphenidate—Abdominal pain upper—Topiramate—obesity	2.55e-05	0.000513	CcSEcCtD
Methylphenidate—Discomfort—Sibutramine—obesity	2.55e-05	0.000512	CcSEcCtD
Methylphenidate—Muscle spasms—Bupropion—obesity	2.54e-05	0.00051	CcSEcCtD
Methylphenidate—Infection—Orlistat—obesity	2.54e-05	0.00051	CcSEcCtD
Methylphenidate—Breast disorder—Topiramate—obesity	2.52e-05	0.000507	CcSEcCtD
Methylphenidate—Dry mouth—Sibutramine—obesity	2.52e-05	0.000507	CcSEcCtD
Methylphenidate—Nervous system disorder—Orlistat—obesity	2.5e-05	0.000503	CcSEcCtD
Methylphenidate—Nasopharyngitis—Topiramate—obesity	2.5e-05	0.000502	CcSEcCtD
Methylphenidate—Confusional state—Sibutramine—obesity	2.49e-05	0.000501	CcSEcCtD
Methylphenidate—Vision blurred—Bupropion—obesity	2.49e-05	0.0005	CcSEcCtD
Methylphenidate—Skin disorder—Orlistat—obesity	2.48e-05	0.000499	CcSEcCtD
Methylphenidate—Tremor—Bupropion—obesity	2.47e-05	0.000497	CcSEcCtD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—APOE—obesity	2.47e-05	0.00206	CbGpPWpGaD
Methylphenidate—Gastritis—Topiramate—obesity	2.47e-05	0.000497	CcSEcCtD
Methylphenidate—Anaphylactic shock—Sibutramine—obesity	2.47e-05	0.000497	CcSEcCtD
Methylphenidate—Oedema—Sibutramine—obesity	2.47e-05	0.000497	CcSEcCtD
Methylphenidate—Hyperhidrosis—Orlistat—obesity	2.47e-05	0.000496	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Topiramate—obesity	2.46e-05	0.000495	CcSEcCtD
Methylphenidate—Infection—Sibutramine—obesity	2.45e-05	0.000493	CcSEcCtD
Methylphenidate—Ill-defined disorder—Bupropion—obesity	2.45e-05	0.000492	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—GHRL—obesity	2.45e-05	0.00204	CbGpPWpGaD
Methylphenidate—Anaemia—Bupropion—obesity	2.44e-05	0.00049	CcSEcCtD
Methylphenidate—Shock—Sibutramine—obesity	2.43e-05	0.000489	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD4—obesity	2.43e-05	0.00202	CbGpPWpGaD
Methylphenidate—Agitation—Bupropion—obesity	2.43e-05	0.000488	CcSEcCtD
Methylphenidate—Thrombocytopenia—Sibutramine—obesity	2.42e-05	0.000486	CcSEcCtD
Methylphenidate—Asthma—Topiramate—obesity	2.41e-05	0.000485	CcSEcCtD
Methylphenidate—Angioedema—Bupropion—obesity	2.41e-05	0.000485	CcSEcCtD
Methylphenidate—Tachycardia—Sibutramine—obesity	2.41e-05	0.000485	CcSEcCtD
Methylphenidate—SLC6A2—NRF2 pathway—GGT1—obesity	2.41e-05	0.002	CbGpPWpGaD
Methylphenidate—Skin disorder—Sibutramine—obesity	2.4e-05	0.000482	CcSEcCtD
Methylphenidate—Hyperhidrosis—Sibutramine—obesity	2.39e-05	0.00048	CcSEcCtD
Methylphenidate—Malaise—Bupropion—obesity	2.38e-05	0.000478	CcSEcCtD
Methylphenidate—Vertigo—Bupropion—obesity	2.37e-05	0.000477	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—ADIPOQ—obesity	2.37e-05	0.00197	CbGpPWpGaD
Methylphenidate—Syncope—Bupropion—obesity	2.37e-05	0.000476	CcSEcCtD
Methylphenidate—Pancreatitis—Topiramate—obesity	2.37e-05	0.000476	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—GNB3—obesity	2.36e-05	0.00197	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—obesity	2.36e-05	0.00197	CbGpPWpGaD
Methylphenidate—Leukopenia—Bupropion—obesity	2.36e-05	0.000475	CcSEcCtD
Methylphenidate—Anorexia—Sibutramine—obesity	2.36e-05	0.000473	CcSEcCtD
Methylphenidate—Angina pectoris—Topiramate—obesity	2.35e-05	0.000473	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—LCN2—obesity	2.34e-05	0.00195	CbGpPWpGaD
Methylphenidate—Palpitations—Bupropion—obesity	2.33e-05	0.000469	CcSEcCtD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—HK1—obesity	2.33e-05	0.00194	CbGpPWpGaD
Methylphenidate—Musculoskeletal discomfort—Orlistat—obesity	2.33e-05	0.000468	CcSEcCtD
Methylphenidate—Bronchitis—Topiramate—obesity	2.32e-05	0.000467	CcSEcCtD
Methylphenidate—Loss of consciousness—Bupropion—obesity	2.32e-05	0.000466	CcSEcCtD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—obesity	2.32e-05	0.00193	CbGpPWpGaD
Methylphenidate—Abdominal discomfort—Topiramate—obesity	2.31e-05	0.000465	CcSEcCtD
Methylphenidate—Insomnia—Orlistat—obesity	2.31e-05	0.000464	CcSEcCtD
Methylphenidate—Cough—Bupropion—obesity	2.3e-05	0.000463	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—NQO1—obesity	2.3e-05	0.00191	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—obesity	2.3e-05	0.00191	CbGpPWpGaD
Methylphenidate—Paraesthesia—Orlistat—obesity	2.29e-05	0.000461	CcSEcCtD
Methylphenidate—Pancytopenia—Topiramate—obesity	2.29e-05	0.000461	CcSEcCtD
Methylphenidate—Convulsion—Bupropion—obesity	2.29e-05	0.00046	CcSEcCtD
Methylphenidate—Hypertension—Bupropion—obesity	2.28e-05	0.000458	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD2—obesity	2.26e-05	0.00188	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—TNF—obesity	2.26e-05	0.00188	CbGpPWpGaD
Methylphenidate—Musculoskeletal discomfort—Sibutramine—obesity	2.25e-05	0.000453	CcSEcCtD
Methylphenidate—Dyspepsia—Orlistat—obesity	2.25e-05	0.000452	CcSEcCtD
Methylphenidate—Arthralgia—Bupropion—obesity	2.25e-05	0.000452	CcSEcCtD
Methylphenidate—Myalgia—Bupropion—obesity	2.25e-05	0.000452	CcSEcCtD
Methylphenidate—Chest pain—Bupropion—obesity	2.25e-05	0.000452	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRA6—obesity	2.24e-05	0.00187	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—FTL—obesity	2.24e-05	0.00187	CbGpPWpGaD
Methylphenidate—Upper respiratory tract infection—Topiramate—obesity	2.24e-05	0.000451	CcSEcCtD
Methylphenidate—Anxiety—Bupropion—obesity	2.24e-05	0.00045	CcSEcCtD
Methylphenidate—Insomnia—Sibutramine—obesity	2.23e-05	0.000449	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	2.23e-05	0.000449	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—KCNMA1—obesity	2.23e-05	0.00185	CbGpPWpGaD
Methylphenidate—Erectile dysfunction—Topiramate—obesity	2.22e-05	0.000447	CcSEcCtD
Methylphenidate—Discomfort—Bupropion—obesity	2.22e-05	0.000446	CcSEcCtD
Methylphenidate—Decreased appetite—Orlistat—obesity	2.22e-05	0.000446	CcSEcCtD
Methylphenidate—Paraesthesia—Sibutramine—obesity	2.22e-05	0.000446	CcSEcCtD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	2.22e-05	0.00184	CbGpPWpGaD
Methylphenidate—Gastrointestinal disorder—Orlistat—obesity	2.2e-05	0.000443	CcSEcCtD
Methylphenidate—Dyspnoea—Sibutramine—obesity	2.2e-05	0.000443	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Topiramate—obesity	2.2e-05	0.000443	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—SLC2A4—obesity	2.2e-05	0.00183	CbGpPWpGaD
Methylphenidate—Fatigue—Orlistat—obesity	2.2e-05	0.000442	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—COX7C—obesity	2.2e-05	0.00183	CbGpPWpGaD
Methylphenidate—Dry mouth—Bupropion—obesity	2.2e-05	0.000442	CcSEcCtD
Methylphenidate—Somnolence—Sibutramine—obesity	2.2e-05	0.000442	CcSEcCtD
Methylphenidate—Weight increased—Topiramate—obesity	2.2e-05	0.000442	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL10—obesity	2.19e-05	0.00182	CbGpPWpGaD
Methylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—obesity	2.19e-05	0.00182	CbGpPWpGaD
Methylphenidate—Weight decreased—Topiramate—obesity	2.18e-05	0.000439	CcSEcCtD
Methylphenidate—Pain—Orlistat—obesity	2.18e-05	0.000439	CcSEcCtD
Methylphenidate—Dyspepsia—Sibutramine—obesity	2.17e-05	0.000437	CcSEcCtD
Methylphenidate—Confusional state—Bupropion—obesity	2.17e-05	0.000437	CcSEcCtD
Methylphenidate—Pneumonia—Topiramate—obesity	2.16e-05	0.000435	CcSEcCtD
Methylphenidate—Oedema—Bupropion—obesity	2.15e-05	0.000433	CcSEcCtD
Methylphenidate—Anaphylactic shock—Bupropion—obesity	2.15e-05	0.000433	CcSEcCtD
Methylphenidate—Infestation NOS—Topiramate—obesity	2.15e-05	0.000433	CcSEcCtD
Methylphenidate—Infestation—Topiramate—obesity	2.15e-05	0.000433	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A14—obesity	2.15e-05	0.00179	CbGpPWpGaD
Methylphenidate—Decreased appetite—Sibutramine—obesity	2.15e-05	0.000432	CcSEcCtD
Methylphenidate—Depression—Topiramate—obesity	2.15e-05	0.000431	CcSEcCtD
Methylphenidate—Infection—Bupropion—obesity	2.14e-05	0.00043	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Topiramate—obesity	2.13e-05	0.000429	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Sibutramine—obesity	2.13e-05	0.000429	CcSEcCtD
Methylphenidate—SLC6A2—NRF2 pathway—HMOX1—obesity	2.13e-05	0.00177	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—GGT1—obesity	2.13e-05	0.00177	CbGpPWpGaD
Methylphenidate—Shock—Bupropion—obesity	2.12e-05	0.000426	CcSEcCtD
Methylphenidate—Pain—Sibutramine—obesity	2.11e-05	0.000425	CcSEcCtD
Methylphenidate—Constipation—Sibutramine—obesity	2.11e-05	0.000425	CcSEcCtD
Methylphenidate—Nervous system disorder—Bupropion—obesity	2.11e-05	0.000425	CcSEcCtD
Methylphenidate—Thrombocytopenia—Bupropion—obesity	2.11e-05	0.000424	CcSEcCtD
Methylphenidate—Feeling abnormal—Orlistat—obesity	2.1e-05	0.000423	CcSEcCtD
Methylphenidate—Tachycardia—Bupropion—obesity	2.1e-05	0.000423	CcSEcCtD
Methylphenidate—Skin disorder—Bupropion—obesity	2.09e-05	0.000421	CcSEcCtD
Methylphenidate—Conjunctivitis—Topiramate—obesity	2.09e-05	0.00042	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Orlistat—obesity	2.09e-05	0.00042	CcSEcCtD
Methylphenidate—Hyperhidrosis—Bupropion—obesity	2.08e-05	0.000419	CcSEcCtD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC22A1—obesity	2.05e-05	0.00171	CbGpPWpGaD
Methylphenidate—Anorexia—Bupropion—obesity	2.05e-05	0.000413	CcSEcCtD
Methylphenidate—Haematuria—Topiramate—obesity	2.05e-05	0.000412	CcSEcCtD
Methylphenidate—Feeling abnormal—Sibutramine—obesity	2.04e-05	0.000409	CcSEcCtD
Methylphenidate—Epistaxis—Topiramate—obesity	2.03e-05	0.000408	CcSEcCtD
Methylphenidate—Urticaria—Orlistat—obesity	2.03e-05	0.000408	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—NR3C1—obesity	2.03e-05	0.00169	CbGpPWpGaD
Methylphenidate—Gastrointestinal pain—Sibutramine—obesity	2.02e-05	0.000406	CcSEcCtD
Methylphenidate—Sinusitis—Topiramate—obesity	2.02e-05	0.000406	CcSEcCtD
Methylphenidate—Body temperature increased—Orlistat—obesity	2.02e-05	0.000406	CcSEcCtD
Methylphenidate—Abdominal pain—Orlistat—obesity	2.02e-05	0.000406	CcSEcCtD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—GCK—obesity	2.01e-05	0.00168	CbGpPWpGaD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	2e-05	0.00167	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRA6—obesity	1.99e-05	0.00165	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—FTL—obesity	1.99e-05	0.00165	CbGpPWpGaD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	1.98e-05	0.00164	CbGpPWpGaD
Methylphenidate—Bradycardia—Topiramate—obesity	1.97e-05	0.000395	CcSEcCtD
Methylphenidate—Urticaria—Sibutramine—obesity	1.96e-05	0.000395	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Bupropion—obesity	1.96e-05	0.000395	CcSEcCtD
Methylphenidate—Body temperature increased—Sibutramine—obesity	1.95e-05	0.000393	CcSEcCtD
Methylphenidate—Abdominal pain—Sibutramine—obesity	1.95e-05	0.000393	CcSEcCtD
Methylphenidate—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—obesity	1.95e-05	0.00162	CbGpPWpGaD
Methylphenidate—Insomnia—Bupropion—obesity	1.95e-05	0.000392	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—SLC22A1—obesity	1.94e-05	0.00162	CbGpPWpGaD
Methylphenidate—Haemoglobin—Topiramate—obesity	1.94e-05	0.00039	CcSEcCtD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—obesity	1.94e-05	0.00161	CbGpPWpGaD
Methylphenidate—Rhinitis—Topiramate—obesity	1.94e-05	0.000389	CcSEcCtD
Methylphenidate—Paraesthesia—Bupropion—obesity	1.93e-05	0.000389	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—CYP26B1—obesity	1.93e-05	0.00161	CbGpPWpGaD
Methylphenidate—Haemorrhage—Topiramate—obesity	1.93e-05	0.000388	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—PPARGC1A—obesity	1.93e-05	0.00161	CbGpPWpGaD
Methylphenidate—Hallucination—Topiramate—obesity	1.92e-05	0.000386	CcSEcCtD
Methylphenidate—Dyspnoea—Bupropion—obesity	1.92e-05	0.000386	CcSEcCtD
Methylphenidate—Pharyngitis—Topiramate—obesity	1.92e-05	0.000385	CcSEcCtD
Methylphenidate—Somnolence—Bupropion—obesity	1.91e-05	0.000385	CcSEcCtD
Methylphenidate—Urinary tract disorder—Topiramate—obesity	1.91e-05	0.000383	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP26B1—obesity	1.91e-05	0.00159	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC6A14—obesity	1.91e-05	0.00159	CbGpPWpGaD
Methylphenidate—Connective tissue disorder—Topiramate—obesity	1.9e-05	0.000382	CcSEcCtD
Methylphenidate—Dyspepsia—Bupropion—obesity	1.9e-05	0.000381	CcSEcCtD
Methylphenidate—Urethral disorder—Topiramate—obesity	1.89e-05	0.000381	CcSEcCtD
Methylphenidate—SLC6A3—NRF2 pathway—HMOX1—obesity	1.89e-05	0.00157	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Orlistat—obesity	1.88e-05	0.000378	CcSEcCtD
Methylphenidate—Decreased appetite—Bupropion—obesity	1.87e-05	0.000376	CcSEcCtD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—BCHE—obesity	1.87e-05	0.00156	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—SIRT1—obesity	1.87e-05	0.00155	CbGpPWpGaD
Methylphenidate—Visual impairment—Topiramate—obesity	1.86e-05	0.000374	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Bupropion—obesity	1.86e-05	0.000374	CcSEcCtD
Methylphenidate—Fatigue—Bupropion—obesity	1.86e-05	0.000373	CcSEcCtD
Methylphenidate—Pain—Bupropion—obesity	1.84e-05	0.00037	CcSEcCtD
Methylphenidate—Constipation—Bupropion—obesity	1.84e-05	0.00037	CcSEcCtD
Methylphenidate—Asthenia—Orlistat—obesity	1.83e-05	0.000368	CcSEcCtD
Methylphenidate—Erythema multiforme—Topiramate—obesity	1.83e-05	0.000367	CcSEcCtD
Methylphenidate—Hypersensitivity—Sibutramine—obesity	1.82e-05	0.000366	CcSEcCtD
Methylphenidate—Pruritus—Orlistat—obesity	1.81e-05	0.000363	CcSEcCtD
Methylphenidate—Eye disorder—Topiramate—obesity	1.81e-05	0.000363	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—obesity	1.8e-05	0.0015	CbGpPWpGaD
Methylphenidate—Flushing—Topiramate—obesity	1.79e-05	0.00036	CcSEcCtD
Methylphenidate—Cardiac disorder—Topiramate—obesity	1.79e-05	0.00036	CcSEcCtD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—GCK—obesity	1.78e-05	0.00149	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC9A3—obesity	1.78e-05	0.00148	CbGpPWpGaD
Methylphenidate—Feeling abnormal—Bupropion—obesity	1.77e-05	0.000357	CcSEcCtD
Methylphenidate—Asthenia—Sibutramine—obesity	1.77e-05	0.000356	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Bupropion—obesity	1.76e-05	0.000354	CcSEcCtD
Methylphenidate—Angiopathy—Topiramate—obesity	1.75e-05	0.000352	CcSEcCtD
Methylphenidate—Pruritus—Sibutramine—obesity	1.75e-05	0.000351	CcSEcCtD
Methylphenidate—Diarrhoea—Orlistat—obesity	1.75e-05	0.000351	CcSEcCtD
Methylphenidate—Immune system disorder—Topiramate—obesity	1.74e-05	0.000351	CcSEcCtD
Methylphenidate—Mediastinal disorder—Topiramate—obesity	1.74e-05	0.00035	CcSEcCtD
Methylphenidate—Chills—Topiramate—obesity	1.73e-05	0.000348	CcSEcCtD
Methylphenidate—Urticaria—Bupropion—obesity	1.71e-05	0.000344	CcSEcCtD
Methylphenidate—Alopecia—Topiramate—obesity	1.71e-05	0.000343	CcSEcCtD
Methylphenidate—Abdominal pain—Bupropion—obesity	1.7e-05	0.000342	CcSEcCtD
Methylphenidate—Body temperature increased—Bupropion—obesity	1.7e-05	0.000342	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HK2—obesity	1.7e-05	0.00141	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—ADH1B—obesity	1.69e-05	0.00141	CbGpPWpGaD
Methylphenidate—Mental disorder—Topiramate—obesity	1.69e-05	0.00034	CcSEcCtD
Methylphenidate—Diarrhoea—Sibutramine—obesity	1.69e-05	0.00034	CcSEcCtD
Methylphenidate—Dizziness—Orlistat—obesity	1.69e-05	0.000339	CcSEcCtD
Methylphenidate—Erythema—Topiramate—obesity	1.68e-05	0.000338	CcSEcCtD
Methylphenidate—Malnutrition—Topiramate—obesity	1.68e-05	0.000338	CcSEcCtD
Methylphenidate—Tension—Topiramate—obesity	1.65e-05	0.000332	CcSEcCtD
Methylphenidate—Dizziness—Sibutramine—obesity	1.63e-05	0.000328	CcSEcCtD
Methylphenidate—Nervousness—Topiramate—obesity	1.63e-05	0.000328	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC27A1—obesity	1.63e-05	0.00136	CbGpPWpGaD
Methylphenidate—Back pain—Topiramate—obesity	1.63e-05	0.000327	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—NCOA1—obesity	1.62e-05	0.00135	CbGpPWpGaD
Methylphenidate—Vomiting—Orlistat—obesity	1.62e-05	0.000326	CcSEcCtD
Methylphenidate—Muscle spasms—Topiramate—obesity	1.62e-05	0.000325	CcSEcCtD
Methylphenidate—Rash—Orlistat—obesity	1.61e-05	0.000324	CcSEcCtD
Methylphenidate—Dermatitis—Orlistat—obesity	1.61e-05	0.000323	CcSEcCtD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—obesity	1.6e-05	0.00133	CbGpPWpGaD
Methylphenidate—Headache—Orlistat—obesity	1.6e-05	0.000322	CcSEcCtD
Methylphenidate—Hypersensitivity—Bupropion—obesity	1.59e-05	0.000319	CcSEcCtD
Methylphenidate—Vision blurred—Topiramate—obesity	1.58e-05	0.000319	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC9A3—obesity	1.58e-05	0.00131	CbGpPWpGaD
Methylphenidate—Tremor—Topiramate—obesity	1.58e-05	0.000317	CcSEcCtD
Methylphenidate—Vomiting—Sibutramine—obesity	1.57e-05	0.000316	CcSEcCtD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—obesity	1.57e-05	0.0013	CbGpPWpGaD
Methylphenidate—Ill-defined disorder—Topiramate—obesity	1.56e-05	0.000314	CcSEcCtD
Methylphenidate—Rash—Sibutramine—obesity	1.56e-05	0.000313	CcSEcCtD
Methylphenidate—Dermatitis—Sibutramine—obesity	1.56e-05	0.000313	CcSEcCtD
Methylphenidate—Anaemia—Topiramate—obesity	1.55e-05	0.000312	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—PPARA—obesity	1.55e-05	0.00129	CbGpPWpGaD
Methylphenidate—Headache—Sibutramine—obesity	1.55e-05	0.000311	CcSEcCtD
Methylphenidate—Asthenia—Bupropion—obesity	1.55e-05	0.000311	CcSEcCtD
Methylphenidate—Agitation—Topiramate—obesity	1.55e-05	0.000311	CcSEcCtD
Methylphenidate—Pruritus—Bupropion—obesity	1.52e-05	0.000306	CcSEcCtD
Methylphenidate—Nausea—Orlistat—obesity	1.52e-05	0.000305	CcSEcCtD
Methylphenidate—Malaise—Topiramate—obesity	1.52e-05	0.000305	CcSEcCtD
Methylphenidate—Vertigo—Topiramate—obesity	1.51e-05	0.000304	CcSEcCtD
Methylphenidate—Syncope—Topiramate—obesity	1.51e-05	0.000303	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HK2—obesity	1.51e-05	0.00125	CbGpPWpGaD
Methylphenidate—Leukopenia—Topiramate—obesity	1.51e-05	0.000303	CcSEcCtD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—COMT—obesity	1.5e-05	0.00125	CbGpPWpGaD
Methylphenidate—Palpitations—Topiramate—obesity	1.49e-05	0.000299	CcSEcCtD
Methylphenidate—Loss of consciousness—Topiramate—obesity	1.48e-05	0.000297	CcSEcCtD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GNB3—obesity	1.48e-05	0.00123	CbGpPWpGaD
Methylphenidate—Diarrhoea—Bupropion—obesity	1.47e-05	0.000296	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—LEP—obesity	1.47e-05	0.00123	CbGpPWpGaD
Methylphenidate—Nausea—Sibutramine—obesity	1.47e-05	0.000295	CcSEcCtD
Methylphenidate—Cough—Topiramate—obesity	1.47e-05	0.000295	CcSEcCtD
Methylphenidate—Convulsion—Topiramate—obesity	1.46e-05	0.000293	CcSEcCtD
Methylphenidate—Hypertension—Topiramate—obesity	1.45e-05	0.000292	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC27A1—obesity	1.44e-05	0.0012	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—BCHE—obesity	1.43e-05	0.00119	CbGpPWpGaD
Methylphenidate—Myalgia—Topiramate—obesity	1.43e-05	0.000288	CcSEcCtD
Methylphenidate—Arthralgia—Topiramate—obesity	1.43e-05	0.000288	CcSEcCtD
Methylphenidate—Chest pain—Topiramate—obesity	1.43e-05	0.000288	CcSEcCtD
Methylphenidate—Anxiety—Topiramate—obesity	1.43e-05	0.000287	CcSEcCtD
Methylphenidate—Dizziness—Bupropion—obesity	1.42e-05	0.000286	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	1.42e-05	0.000286	CcSEcCtD
Methylphenidate—Discomfort—Topiramate—obesity	1.41e-05	0.000284	CcSEcCtD
Methylphenidate—Dry mouth—Topiramate—obesity	1.4e-05	0.000281	CcSEcCtD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC2A4—obesity	1.39e-05	0.00115	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TRPV1—obesity	1.39e-05	0.00115	CbGpPWpGaD
Methylphenidate—Confusional state—Topiramate—obesity	1.38e-05	0.000278	CcSEcCtD
Methylphenidate—Oedema—Topiramate—obesity	1.37e-05	0.000276	CcSEcCtD
Methylphenidate—Vomiting—Bupropion—obesity	1.37e-05	0.000275	CcSEcCtD
Methylphenidate—Infection—Topiramate—obesity	1.36e-05	0.000274	CcSEcCtD
Methylphenidate—Rash—Bupropion—obesity	1.36e-05	0.000273	CcSEcCtD
Methylphenidate—Dermatitis—Bupropion—obesity	1.36e-05	0.000273	CcSEcCtD
Methylphenidate—Shock—Topiramate—obesity	1.35e-05	0.000271	CcSEcCtD
Methylphenidate—Headache—Bupropion—obesity	1.35e-05	0.000271	CcSEcCtD
Methylphenidate—Nervous system disorder—Topiramate—obesity	1.35e-05	0.000271	CcSEcCtD
Methylphenidate—Thrombocytopenia—Topiramate—obesity	1.34e-05	0.00027	CcSEcCtD
Methylphenidate—Tachycardia—Topiramate—obesity	1.34e-05	0.000269	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HK1—obesity	1.33e-05	0.00111	CbGpPWpGaD
Methylphenidate—Skin disorder—Topiramate—obesity	1.33e-05	0.000268	CcSEcCtD
Methylphenidate—Hyperhidrosis—Topiramate—obesity	1.33e-05	0.000267	CcSEcCtD
Methylphenidate—Anorexia—Topiramate—obesity	1.31e-05	0.000263	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—SULT2A1—obesity	1.31e-05	0.00109	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—SULT2A1—obesity	1.29e-05	0.00107	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—PPARG—obesity	1.28e-05	0.00107	CbGpPWpGaD
Methylphenidate—Nausea—Bupropion—obesity	1.28e-05	0.000257	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Topiramate—obesity	1.25e-05	0.000251	CcSEcCtD
Methylphenidate—Insomnia—Topiramate—obesity	1.24e-05	0.00025	CcSEcCtD
Methylphenidate—Paraesthesia—Topiramate—obesity	1.23e-05	0.000248	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—GPX3—obesity	1.23e-05	0.00102	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TRPV1—obesity	1.23e-05	0.00102	CbGpPWpGaD
Methylphenidate—Dyspnoea—Topiramate—obesity	1.22e-05	0.000246	CcSEcCtD
Methylphenidate—Somnolence—Topiramate—obesity	1.22e-05	0.000245	CcSEcCtD
Methylphenidate—Dyspepsia—Topiramate—obesity	1.21e-05	0.000243	CcSEcCtD
Methylphenidate—Decreased appetite—Topiramate—obesity	1.19e-05	0.00024	CcSEcCtD
Methylphenidate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—obesity	1.19e-05	0.000988	CbGpPWpGaD
Methylphenidate—Gastrointestinal disorder—Topiramate—obesity	1.18e-05	0.000238	CcSEcCtD
Methylphenidate—Fatigue—Topiramate—obesity	1.18e-05	0.000238	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HK1—obesity	1.18e-05	0.000984	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC22A1—obesity	1.18e-05	0.000981	CbGpPWpGaD
Methylphenidate—Constipation—Topiramate—obesity	1.17e-05	0.000236	CcSEcCtD
Methylphenidate—Pain—Topiramate—obesity	1.17e-05	0.000236	CcSEcCtD
Methylphenidate—SLC6A4—Circadian rythm related genes—SERPINE1—obesity	1.16e-05	0.000961	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL1B—obesity	1.15e-05	0.000957	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—COMT—obesity	1.15e-05	0.000954	CbGpPWpGaD
Methylphenidate—Feeling abnormal—Topiramate—obesity	1.13e-05	0.000227	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—GNB3—obesity	1.13e-05	0.000941	CbGpPWpGaD
Methylphenidate—Gastrointestinal pain—Topiramate—obesity	1.12e-05	0.000226	CcSEcCtD
Methylphenidate—Urticaria—Topiramate—obesity	1.09e-05	0.000219	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PRKAR2B—obesity	1.09e-05	0.000905	CbGpPWpGaD
Methylphenidate—Body temperature increased—Topiramate—obesity	1.08e-05	0.000218	CcSEcCtD
Methylphenidate—Abdominal pain—Topiramate—obesity	1.08e-05	0.000218	CcSEcCtD
Methylphenidate—CYP2D6—Metapathway biotransformation—AKR1C3—obesity	1.08e-05	0.000896	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—PRKCB—obesity	1.06e-05	0.000884	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC22A1—obesity	1.04e-05	0.000869	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—GCK—obesity	1.02e-05	0.000852	CbGpPWpGaD
Methylphenidate—Hypersensitivity—Topiramate—obesity	1.01e-05	0.000203	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—CETP—obesity	9.88e-06	0.000822	CbGpPWpGaD
Methylphenidate—Asthenia—Topiramate—obesity	9.85e-06	0.000198	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TF—obesity	9.77e-06	0.000813	CbGpPWpGaD
Methylphenidate—Pruritus—Topiramate—obesity	9.71e-06	0.000195	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PRKAR2B—obesity	9.64e-06	0.000802	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—obesity	9.62e-06	0.000801	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—CYP2E1—obesity	9.54e-06	0.000794	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—TGFB1—obesity	9.42e-06	0.000784	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP2E1—obesity	9.41e-06	0.000783	CbGpPWpGaD
Methylphenidate—Diarrhoea—Topiramate—obesity	9.39e-06	0.000189	CcSEcCtD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—TFRC—obesity	9.36e-06	0.000779	CbGpPWpGaD
Methylphenidate—Dizziness—Topiramate—obesity	9.07e-06	0.000182	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—GCK—obesity	9.07e-06	0.000755	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—GGT1—obesity	8.76e-06	0.000729	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—CETP—obesity	8.75e-06	0.000728	CbGpPWpGaD
Methylphenidate—Vomiting—Topiramate—obesity	8.72e-06	0.000175	CcSEcCtD
Methylphenidate—Rash—Topiramate—obesity	8.65e-06	0.000174	CcSEcCtD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TF—obesity	8.65e-06	0.00072	CbGpPWpGaD
Methylphenidate—Dermatitis—Topiramate—obesity	8.64e-06	0.000174	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—NCOA1—obesity	8.63e-06	0.000718	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—MAPK8—obesity	8.61e-06	0.000716	CbGpPWpGaD
Methylphenidate—Headache—Topiramate—obesity	8.6e-06	0.000173	CcSEcCtD
Methylphenidate—CYP2D6—Biological oxidations—CYP19A1—obesity	8.51e-06	0.000708	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—CYP19A1—obesity	8.39e-06	0.000698	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TNF—obesity	8.34e-06	0.000694	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—TFRC—obesity	8.29e-06	0.00069	CbGpPWpGaD
Methylphenidate—Nausea—Topiramate—obesity	8.15e-06	0.000164	CcSEcCtD
Methylphenidate—SLC6A3—Neuronal System—PRKCB—obesity	8.14e-06	0.000677	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—TGFB1—obesity	8.1e-06	0.000674	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—ALB—obesity	8.07e-06	0.000672	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC2A4—obesity	7.96e-06	0.000663	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CA3—obesity	7.96e-06	0.000662	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—COMT—obesity	7.91e-06	0.000658	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—CYCS—obesity	7.86e-06	0.000654	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—COMT—obesity	7.8e-06	0.000649	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—NCOA1—obesity	7.6e-06	0.000632	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PLG—obesity	7.4e-06	0.000616	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—TGFB1—obesity	7.18e-06	0.000597	CbGpPWpGaD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—ALB—obesity	7.15e-06	0.000595	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC2A4—obesity	7.05e-06	0.000587	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—CYCS—obesity	6.96e-06	0.000579	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—GNB3—obesity	6.86e-06	0.000571	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—HMOX1—obesity	6.83e-06	0.000568	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GLRX—obesity	6.77e-06	0.000563	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—IL6—obesity	6.73e-06	0.00056	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—NCOA1—obesity	6.73e-06	0.00056	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—GNAS—obesity	6.68e-06	0.000556	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PLG—obesity	6.56e-06	0.000546	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—APOB—obesity	6.54e-06	0.000544	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—GNB3—obesity	6.08e-06	0.000506	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—HMOX1—obesity	6.05e-06	0.000504	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—OTC—obesity	6.03e-06	0.000502	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—INSIG2—obesity	6.03e-06	0.000502	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPM1L—obesity	6.03e-06	0.000502	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ETFDH—obesity	6.03e-06	0.000502	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—GNAS—obesity	5.92e-06	0.000493	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—APOB—obesity	5.8e-06	0.000482	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—PPARA—obesity	5.52e-06	0.000459	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UQCRC2—obesity	5.52e-06	0.000459	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPT—obesity	5.52e-06	0.000459	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—INPP5E—obesity	5.52e-06	0.000459	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—IL6—obesity	5.5e-06	0.000457	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—APOA1—obesity	5.18e-06	0.000431	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ME1—obesity	5.13e-06	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALDH6A1—obesity	5.13e-06	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SUCLG2—obesity	5.13e-06	0.000427	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—POMC—obesity	5.11e-06	0.000425	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—PPARA—obesity	4.89e-06	0.000407	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PNPLA3—obesity	4.82e-06	0.000401	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UCP1—obesity	4.82e-06	0.000401	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—COX7C—obesity	4.82e-06	0.000401	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—APOA1—obesity	4.59e-06	0.000382	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CS—obesity	4.57e-06	0.00038	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DGAT2—obesity	4.57e-06	0.00038	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SUCLA2—obesity	4.57e-06	0.00038	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CPS1—obesity	4.57e-06	0.00038	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LIPE—obesity	4.36e-06	0.000363	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MUT—obesity	4.36e-06	0.000363	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYB5A—obesity	4.18e-06	0.000348	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DGAT1—obesity	4.18e-06	0.000348	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—ALB—obesity	4.1e-06	0.000341	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ACLY—obesity	4.02e-06	0.000335	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ENPP1—obesity	3.89e-06	0.000323	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALOX12—obesity	3.89e-06	0.000323	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMGCS1—obesity	3.76e-06	0.000313	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ACADM—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ANGPTL4—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PFKFB3—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SAT1—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PNPLA2—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PLIN1—obesity	3.65e-06	0.000304	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—ALB—obesity	3.63e-06	0.000302	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—OXCT1—obesity	3.55e-06	0.000296	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ACACB—obesity	3.55e-06	0.000296	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYTB—obesity	3.55e-06	0.000296	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SRD5A1—obesity	3.46e-06	0.000288	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PNLIP—obesity	3.46e-06	0.000288	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SDC3—obesity	3.38e-06	0.000281	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HK2—obesity	3.3e-06	0.000275	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP26B1—obesity	3.3e-06	0.000275	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—STS—obesity	3.3e-06	0.000275	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARD—obesity	3.23e-06	0.000269	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC27A1—obesity	3.17e-06	0.000264	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—FABP4—obesity	3.11e-06	0.000259	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GLUL—obesity	3.11e-06	0.000259	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HSD11B1—obesity	2.95e-06	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UCP3—obesity	2.95e-06	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—UCP2—obesity	2.95e-06	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ECHS1—obesity	2.95e-06	0.000245	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ADH1B—obesity	2.9e-06	0.000241	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ACSL1—obesity	2.85e-06	0.000237	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPAM—obesity	2.85e-06	0.000237	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARGC1B—obesity	2.85e-06	0.000237	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PCK1—obesity	2.77e-06	0.00023	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HADH—obesity	2.77e-06	0.00023	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—FADS1—obesity	2.77e-06	0.00023	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ACP5—obesity	2.69e-06	0.000224	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—G6PD—obesity	2.63e-06	0.000218	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HK1—obesity	2.59e-06	0.000216	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SREBF2—obesity	2.59e-06	0.000216	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LPA—obesity	2.5e-06	0.000208	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LPIN1—obesity	2.45e-06	0.000204	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA5—obesity	2.4e-06	0.0002	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CLOCK—obesity	2.29e-06	0.000191	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC22A1—obesity	2.29e-06	0.000191	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SULT2A1—obesity	2.23e-06	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GLP1R—obesity	2.23e-06	0.000186	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DPYD—obesity	2.2e-06	0.000183	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PRKAR2B—obesity	2.11e-06	0.000176	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DCN—obesity	2.1e-06	0.000175	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CPT1A—obesity	2.04e-06	0.00017	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NAMPT—obesity	2e-06	0.000167	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LIPC—obesity	1.99e-06	0.000166	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GCK—obesity	1.99e-06	0.000166	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOC3—obesity	1.98e-06	0.000165	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CETP—obesity	1.92e-06	0.00016	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SDC1—obesity	1.9e-06	0.000158	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AKR1C3—obesity	1.87e-06	0.000155	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SCARB1—obesity	1.84e-06	0.000153	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SREBF1—obesity	1.78e-06	0.000149	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GOT2—obesity	1.74e-06	0.000144	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—FASN—obesity	1.7e-06	0.000141	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—BCHE—obesity	1.69e-06	0.000141	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP2E1—obesity	1.63e-06	0.000136	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NQO1—obesity	1.61e-06	0.000134	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SLC2A4—obesity	1.55e-06	0.000129	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GCG—obesity	1.55e-06	0.000129	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYCS—obesity	1.53e-06	0.000127	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GGT1—obesity	1.5e-06	0.000125	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GOT1—obesity	1.5e-06	0.000125	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NCOA1—obesity	1.48e-06	0.000123	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CYP19A1—obesity	1.45e-06	0.000121	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—STK11—obesity	1.45e-06	0.000121	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—COMT—obesity	1.35e-06	0.000113	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GNB3—obesity	1.33e-06	0.000111	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARGC1A—obesity	1.33e-06	0.000111	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—HMOX1—obesity	1.33e-06	0.00011	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GNAS—obesity	1.3e-06	0.000108	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOB—obesity	1.27e-06	0.000106	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—LPL—obesity	1.21e-06	0.000101	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—GPX1—obesity	1.18e-06	9.86e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CD36—obesity	1.15e-06	9.6e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MTHFR—obesity	1.09e-06	9.1e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARA—obesity	1.07e-06	8.92e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AGT—obesity	1.04e-06	8.64e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOE—obesity	1.02e-06	8.47e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CAV1—obesity	1.01e-06	8.39e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—APOA1—obesity	1.01e-06	8.37e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3CG—obesity	9.19e-07	7.64e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PPARG—obesity	8.87e-07	7.38e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—POMC—obesity	8.74e-07	7.28e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—INS—obesity	8.69e-07	7.24e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3CD—obesity	8.07e-07	6.72e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ALB—obesity	7.97e-07	6.63e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—NOS3—obesity	7.62e-07	6.34e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3R1—obesity	7.62e-07	6.34e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3CB—obesity	7.04e-07	5.86e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PTGS2—obesity	6.97e-07	5.8e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—PIK3CA—obesity	4.29e-07	3.57e-05	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—AKT1—obesity	3.5e-07	2.92e-05	CbGpPWpGaD
